AstraZeneca PLC (AZN) CEO Pascal Soriot on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/25/19
Pharma Giants Top Second-Quarter Estimates, But Only One Stock PopsInvestors Business Daily • 07/25/19
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug FailuresInvestors Business Daily • 06/14/19
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster HeadacheZacks Investment Research • 06/07/19